Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Utilities Select Sector SPDR Fund — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Utilities Select Sector SPDR Fund trades at $45.36. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ARKG | XLU | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $47.73 |
52-Week Low | $23.09 | $40.99 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XLU, the Utilities Select Sector SPDR ETF, trades at $45.41, up 0.62% on the day, with a bullish technical signal driven by moving averages. The ETF benefits from growing investor interest as AI-driven electricity demand transforms utilities into growth plays, with news highlighting long-term power agreements with tech firms. Key support sits at $45, while resistance is at $46. Recent dividend activity includes a $0.28 distribution scheduled for June 2026.
Outlook: XLU offers defensive exposure with upside from AI power demand, but risks include grid reliability and regulatory hurdles. Wall Street sentiment is positive due to earnings growth potential, though valuation metrics are unspecified. Investors should weigh stable dividends against infrastructure execution challenges in a shifting energy landscape.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →